This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Roche Diabetes Care, Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Nathan Wegmann: Innovator in Blood Glucose Analysis
Introduction
Nathan Wegmann is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of diabetes management through his innovative patent. His work focuses on analyzing blood glucose data to improve insulin therapy outcomes.
Latest Patents
Wegmann holds a patent for a system and methods for analyzing blood glucose data and quantifying the success or failure of insulin therapy. This patent encompasses a comprehensive technique for determining the effectiveness of blood glucose therapy treatments. The system includes analyzing the sufficiency of blood glucose data collected from patients, assessing hypoglycemic risk, evaluating glycemic control, and examining glycemic variability. The results from these analyses are outputted using a computing device, providing valuable insights for healthcare providers.
Career Highlights
Throughout his career, Nathan Wegmann has worked with prominent companies in the healthcare sector, including Roche Diabetes Care, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to diabetes management.
Collaborations
Wegmann has collaborated with several professionals in his field, including Christen A Rees and Robin S Wagner. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Nathan Wegmann's contributions to blood glucose analysis and insulin therapy represent a significant advancement in diabetes care. His innovative patent and collaborative efforts highlight his commitment to improving patient outcomes in this critical area of healthcare.